Berlin-based FEMNA Health, an e-health brand for female health, announced it has received seven-figure growth funding led by existing investors, including Berlin Angel Fund, Atreyu Investments, Cimexia GmbH, IBB Capital GmbH (supported by the KfW/IBB program “BerlinInnoGrowth”), as well as new strategic investors.
The company will use the funds to expand its presence in the women’s health sector.
Additionally, the company is focused on expanding its offerings, including the development of innovative solutions for menstrual health issues, broadening its range of therapies, enhancing its digital platform, and promoting educational initiatives in the women’s health field.
FEMNA Health: Telemedicine platform for women’s hormonal health
Founded by Maxie Matthiessen, FEMNA Health is a telemedicine platform for women’s hormonal health.
The company’s platform allows convenient access to medical doctors and naturopaths for detailed advice and therapeutic recommendations on all topics related to women’s health, from menstrual disorders to family planning and menopausal concerns.
FEMNA majorly offers:
Diagnostics using home testing kits
Virtual access to naturopaths and doctors for consultations
Proprietary and unique product line for the needs and desires of their customers
The company serves aged between 25 and 45 with health concerns majorly related to menstrual disorders, acne, or PMS, which OB-GYN doctors superficially treat with birth control pills.
The German company’s solution empowers women to take control of their health rather than relying on very short and often undifferentiated visits to gynecologist and gives them natural treatment options where possible.
FEMNA served 14,000 women since its inception in 2016.
